Appendino
Giovanni Appendino, Cordoba ES
Patent application number | Description | Published |
---|---|---|
20100222437 | COMPOSITION CONTAINING NON-PSYCHOTROPIC CANNABINOIDS FOR THE TREATMENT OF INFLAMMATORY DISEASES - The invention relates to a composition comprising cannabidiol and Denbinobin and its use in medicine, for example, for the prevention and treatment of gastrointestinal inflammatory diseases and for the prevention and treatment of gastrointestinal cancers. | 09-02-2010 |
20130158126 | CANNABINOID QUINONE DERIVATIVES - Cannabinoid quinone derivatives. The present invention refers to cannabinoid quinone derivatives to be used as medicaments, particularly as PPAR gamma (PPARg) agonists for treating diseases which etiology is based on an impaired PPARg function as transcription factor i.e. PPARg-related diseases. | 06-20-2013 |
20140243551 | METHOD OF ISOLATING INGENOL - The present invention relates to a new method for isolating ingenol (C | 08-28-2014 |
Giovanni Appendino, Universita Del Piemonte Orientale IT
Patent application number | Description | Published |
---|---|---|
20100130498 | AGONISTS OF BITTER TASTE RECEPTORS AND USES THEREOF - The present invention relates to agonists of the human bitter-taste receptors hTAS2R14, hTAS2R10 and hTAS2R4 and their role in bitter taste transduction. The invention also relates to methods for identifying molecules that modulate, e.g. suppress, or enhance hTAS2R14, hTAS2R10 and hTAS2R4 bitter taste transduction or bitter taste response. | 05-27-2010 |
20100184796 | AGONISTS OF BITTER TASTE RECEPTORS AND USES THEREOF - The present invention relates to agonists of the human bitter-taste receptors hTAS2R46, hTAS2R47 and hTAS2R50 and their role in bitter taste transduction. The invention also relates to methods for identifying molecules that modulate, e.g. suppress, or enhance hTAS2R46, hTAS2R47 and hTAS2R50 bitter taste transduction or bitter taste response. | 07-22-2010 |
Giovanni Appendino, Novara IT
Patent application number | Description | Published |
---|---|---|
20080242878 | Semi-Synthetic Taxane Derivatives With Antitumor Activity - The invention discloses novel secotaxane derivatives of general formula 1, having cytotoxic activity, which can be administered through the injective or oral route, for the therapy of tumors. | 10-02-2008 |
Giovanni Appendino, Torino IT
Patent application number | Description | Published |
---|---|---|
20120283324 | ANTAGONISTS AND AGONISTS OF BITTER TASTE RECEPTORS AND USES THEREOF - The present invention relates to antagonists and agonists of the human bitter-taste receptors hTAS2R40, hTAS2R43, hTAS2R44, hTAS2R46, and hTAS2R47. The invention also relates to methods for identifying further molecules that suppress or enhance bitter taste transduction or bitter taste response mediated by hTAS2R40, hTAS2R43, hTAS2R44, hTAS2R46, and/or hTAS2R47 and uses thereof. | 11-08-2012 |
Giovanni Appendino, Orientale IT
Patent application number | Description | Published |
---|---|---|
20120309703 | AGONISTS OF BITTER TASTE RECEPTORS AND USES THEREOF - The present invention relates to agonists of the human bitter-taste receptors hTAS2R14, hTAS2R10 and hTAS2R4 and their role in bitter taste transduction. The invention also relates to methods for identifying molecules that modulate, e.g. suppress, or enhance hTAS2R14, hTAS2R10 and hTAS2R4 bitter taste transduction or bitter taste response. | 12-06-2012 |